
Shares of gene sequencing maker Illumina ILMN.O rise 18.5% to $117.4
Co late on Thursday posted Q3 adjusted profit of $1.34 per share, beating analysts' expectations of $1.19 per share, according to data compiled by LSEG
Reported Q3 revenue of $1.08 billion vs estimates of $1.07 billion
ILMN raised its adjusted annual profit forecast to a range of $4.65 to $4.75 per share, up from a previous projection of $4.45 to $4.55 per share
Including session's move, ILMN stock was down 11.5% YTD